TABLE 2.
Correlations of OSMR and SERPINF1–LRP6 with clinicopathological characteristics of gastric cancer.
| Clinicopathological characteristic | OSMR | P | SERPINF1–LRP6 | P | |||
|---|---|---|---|---|---|---|---|
| Low (%) | High (%) | Low (%) | High (%) | ||||
| Tumor positions | Cardia | 2 (12.5) | 14 (87.5) | 0.700 | 6 (37.5) | 10 (62.5) | 0.094 |
| Corpus | 6 (15.4) | 33 (84.6) | 27 (69.2) | 12 (30.8) | |||
| Antrum | 7 (21.2) | 26 (78.8) | 20 (60.6) | 13 (39.4) | |||
| Borrmann typing | I | 0 (0) | 6 (100.0) | 0.290 | 5 (83.3) | 1 (16.7) | 0.619 |
| II | 3 (14.3) | 18 (85.7) | 13 (61.9) | 8 (38.1) | |||
| III | 11 (22.0) | 39 (78.0) | 29 (58.0) | 21 (42.0) | |||
| IV | 1 (9.1) | 10 (83.0) | 6 (54.5) | 5 (45.5) | |||
| T stage | T1–2 | 2 (13.3) | 13 (86.7) | 0.966 | 11 (73.3) | 4 (26.7) | 0.255 |
| T3–4 | 13 (17.8) | 60 (82.2) | 42 (57.5) | 31 (42.5) | |||
| N stage | N0 | 7 (38.9) | 11 (61.1) | 0.010 | 16 (88.9) | 2 (11.1) | 0.018 |
| N1–2 | 6 (17.6) | 28 (82.4) | 19 (55.9) | 15 (44.1) | |||
| N3 | 2 (5.6) | 34 (94.4) | 18 (50.0) | 18 (50.0) | |||
| TNM staging | I | 1 (14.3) | 6 (85.7) | 0.076 | 6 (85.7) | 1 (14.3) | 0.069 |
| II | 8 (32.0) | 17 (68.0) | 18 (72.0) | 7 (28.0) | |||
| III | 6 (10.7) | 50 (89.3) | 29 (51.8) | 27 (48.2) | |||